JEE Advanced 2026 Registration Begins from 23 April, 2026. After the pressure of JEE Main, the next big hurdle for engineering aspirants is finally here. The Indian Institute of Technology is set to ...

JEE Main Result 2026: The percentile score will be the normalised score for the JEE Main examination. JEE Main Result 2026: The Joint Entrance Examination (JEE) Main 2026 result is expected today, ...

The JEE Main Cut off 2026 is the minimum percentile score required for admission to various engineering colleges. This cutoff varies significantly between institutes and is influenced by factors like ...

Harish Shankar’s adaptation of the 2016 Tamil film Theri, Ustaad Bhagat Singh (UBS), was released in theatres on March 19, clashing with Aditya Dhar’s Dhurandhar: The Revenge in the Telugu states.

Netflix shared the update with a special poster. The platform wrote, "The name is Bhagat, but his revolution is his identity ?????Watch Ustaad Bhagat Singh on Netflix, out 16 April, in Telugu, Hindi, ...

Ustaad Bhagat Singh hits Netflix on April 16, 2026. Film received mixed reviews for weak plot and character depth. Box office earnings reached ₹84 crore gross in India. Did our AI summary help? After ...

The wait for Pawan Kalyan fans is finally over as his highly anticipated film Ustaad Bhagat Singh has arrived on the OTT platform Netflix. Those who were eagerly waiting for its digital release can ...

'Ustaad Bhagat Singh ' features Pawan Kalyan in the lead role and the cast includes Sreeleela, Raashi Khanna, R. Parthiban and Nawab Shah in key parts. Harish Shankar directed the project and he ...

JEE Main Session 2 Admit Card: The National Testing Agency has issued the admit card for the second session of the JEE Main examination on its official website, jeemain.nta.nic.in. Applicants can ...

Pawan Kalyan’s latest action film, Ustaad Bhagat Singh, has hit a major slump at the box office. After a promising start, the movie’s earnings dropped sharply on its tenth day, failing to reach Rs 1 ...

March 26 (Reuters) - Wave Life Sciences (WVE.O), opens new tab shares plunged 58% on Thursday after a higher dose of its experimental obesity ‌drug failed to show a clear improvement at reducing a ...